Crescendo Biologics Ltd.
PrivateLast Round
VC Round
Jul 24, 2023
Total Funding Raised
$179.71M
Company Overview
Crescendo Biologics Ltd. is a biotechnology company that develops novel, targeted T-cell enhancing therapeutics based on its proprietary Humabody® VH platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Crescendo Biologics Ltd. Comparables
Compare Crescendo Biologics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leveragen, Inc. | 81% | |
| Isogenica | 80% | |
| AbTherx, Inc. | 79% | |
Crescendo Biologics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 24, 2023 | ||||
| Corporate Funding | Jan 10, 2022 | ||||
| Series B | Apr 30, 2018 | ||||
| VC Round | Dec 16, 2014 | ||||
| Series A | Apr 3, 2014 | ||||
Series A | Dec 17, 2013 |
Crescendo Biologics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | VC Round |
| IP Group | VC Round, Series B |
| Andera Partners | VC Round, Series B |
| Kreos Capital | VC Round |
| UK Innovation & Science Seed Fund | Seed |
| Imperial Innovations | Series A |
| Astellas Venture Management | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2013
$31M round led by Imperial Innovations and Touchstone Innovations.
Crescendo Biologics Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Crescendo Biologics Ltd.'s valuation, stock price, and market status.